Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2310745 | 1.00 | CA1 (0.39) | CA1CA2CA4MGAMGAA | |
| SCHEMBL2310756 | 0.85 | CA1 (0.42) | CA1CA2CA4MGAMGAA | |
| SCHEMBL12166556 | 0.82 | CA1 (0.54) | CA1CA2CA4 | |
| SCHEMBL3480382 | 0.81 | GBA1 (0.39) | CA1CA2CA4GAASI | |
| SCHEMBL597926 | 0.79 | — | — | |
| SCHEMBL597925 | 0.79 | — | — | |
| SCHEMBL598873 | 0.79 | — | — | |
| SCHEMBL598874 | 0.79 | — | — | |
| SCHEMBL597924 | 0.79 | — | — | |
| SCHEMBL10708529 | 0.79 | CA1 (0.41) | CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10343971-B2 | Crotonates having use in perfumery | GIVAUDAN SA (CH) | 2019-07-09 | — | — | US | disclosed |
| US-20190023643-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2019-01-24 | — | — | US | disclosed |
| EP-3416943-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2018-12-26 | — | — | EP | disclosed |
| WO-2017140733-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2017-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343971-B2 | Crotonates having use in perfumery | CROCC, PAX3, H1-3 | CA1 2007/4885CA2 1178/4885CA4 540/4885 |
| US-20190023643-A1 | Organic Compounds | OR10J3, H1-4, H1-0 | CA1 3723/4885CA2 3581/4885CA4 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.